Stock CATX PERSPECTIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.75 USD -2.78% Intraday chart for Perspective Therapeutics, Inc. -3.31% +335.32%
May. 09 Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating MT
Apr. 30 Perspective Therapeutics, Inc. Announces the Selection of Investigational Product VMT-a-NET for the Treatment of Certain Patients with Neuroendocrine Tumors by the U.S. Food and Drug Administration to Participate in the Chemistry CI
36fce360e14cafb05.UNpWxuGIruKYogO1x4FCd_Ij_uc0pxCqWLcQB6XcV34.D5U0hKL_4bb1lDHPkd4MOcsQp6Rd91vpNtwmdvK6NA8ykjeWlceWqcj7Wg~0173067d71c8fa0fdaf56adefd67c254
  1. Stock Market
  2. Equities
  3. CATX Stock
  4. Charts Perspective Therapeutics, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW